Investor Confidence Dwindles After Regulus Therapeutics Inc. (NASDAQ: RGLS) Shares Drop By About -0.04
Regulus Therapeutics Inc (NASDAQ:RGLS) has a beta value of 0.37 and has seen 1.01 million shares traded in the recent trading session. The company, currently